Skip to main content

Ambulatory Surgical Centers Market Growth in Competitive Landscape Mapping the Trends and Outlook

Ambulatory Surgical Centers Market growth can be attributed to the growing need to curtail escalating healthcare costs, shift from inpatient to outpatient surgical procedures, and growing demand for IT solutions such as mhealth, telehealth, and remote patient monitoring for better management.

What the Ambulatory Surgical Centers Market Looks Like?

The Ambulatory surgical centers market is projected to reach USD 7.2 billion by 2025 from 2.1 billion in 2020, at a CAGR of 27.6% during the forecast period. North America will continue to dominate the Ambulatory surgical centers market during the forecast period.


Based on products and services, the Ambulatory surgical centers market is segmented into clinical solutions, non-clinical solutions, and HCIT outsourcing services. In 2019, the clinical solutions segment accounted for the largest share of the Ambulatory surgical centers market. The need to control the increasing healthcare costs and improve the efficiency of healthcare services by reducing medical errors are a major driver that propels the demand for healthcare provider solutions.

Based on components, the Ambulatory surgical centers market is segmented into services, software, and hardware. The services segment accounted for the largest market share in 2019. This is due to the introduction of complex software, the need for integration and interoperability of software, the growing demand for consulting and outsourcing of various healthcare processes such as revenue cycle management, EHR management, and fraud detection.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182183086

What Drives the Ambulatory Surgical Centers Market?

The growth of the global market for Ambulatory Surgical Centers Market is primarily influenced by the following factors:

  • Increasing R&D Expenditure and Funding for Proteomics and Glycomics Research
  • Growth of the Proteomics Market
  • Technological Advancements in Glycomics Instrumentation

The geographical regions mapped in the report are:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographical growth scenario of Ambulatory Surgical Centers Market:

North America accounted for the largest share of the Ambulatory surgical centers market, followed by Europe. The large share of this region can be attributed to the high adoption of Ambulatory surgical centers for reducing the soaring healthcare costs, increasing volume of surgical procedures performed, and the presence of significant market players, such as Epic Systems Corporation (US), Cerner Corporation (US), McKesson Corporation (US), Philips Healthcare (Netherlands), and Allscripts Healthcare Solutions, Inc. (US).

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=182183086

Leading market players and strategies adopted

The prominent players operating in the Ambulatory Surgical Centers Market include Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions, Inc. (US), GE Healthcare (US), Philips Healthcare (Netherlands), athenahealth, Inc. (US), Optum (US), Epic Systems Corporation (US), Medical Information Technology, Inc. (MEDITECH) (US), eClinicalWorks (US), athenahealth, Inc. (US), Advanced Data Systems Corporation (US), NextGen Healthcare (US), CureMD (US), HST Pathways (US), and Surgical Information Systems (US).

Labels:

Comments

Post a Comment

Popular posts from this blog

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs. The  global autoinjectors market  is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). In terms of Therapy, the global autoinjectors market can be segmented into: Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia) By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018 On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therap...
Post a Comment
Read more

Healthcare BPO Market To Reach $312.43 Billion By 2022 : Increasing Consolidation In The Healthcare Industry

  What This Report Will Provide? In the current market scenario, there is a growing demand for healthcare BPO services. The objective of this report is to define, describe, and forecast the market on the basis of outsourcing services including payer, provider, and pharmaceutical services and region. It provides detailed information regarding the major factors influencing the growth of healthcare outsourcing market. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, and financials. Expected Revenue Growth: Healthcare BPO market  is estimated to grow at a CAGR of 10.2% from 2017 to 2022 to reach $312.43 billion by 2022 from $191.68 billion in 2017. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. Major Growth Boosters: Patent cliffs, complex clinical trial protocols, and new reporting requirements are forcing pha...
Post a Comment
Read more

North American Nuclear Medicine Market To Reach USD 2.7 Billion By 2024 – Expansion In Emerging Economies

  What This Report Will Provide? The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Expected Revenue Growth: [159 Pages Report] The  North American nuclear medicine market  is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period. Major Growth Boosters: Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment...
Post a Comment
Read more